Skip to main content

Advertisement

SpringerLink
Log in

Genetic association between cyclin D1 polymorphism and breast cancer susceptibility

  • Research Article
  • Published:
Tumor Biology

Abstract

Cyclin D1 polymorphism has been reported to be associated with risk of breast cancer, but the published studies have yielded controversial results. This study was undertaken to derive a precise risk estimate for the cyclin D1 polymorphism associated with breast cancer risk. We performed a search of EMBASE, PubMed, and Web of Science. In total, data from 18 publications were pooled and the association was assessed by odds ratios (ORs) with 95 % confidence intervals (CIs). This analysis showed that there was no obvious association between the cyclin D1 polymorphism and breast cancer risk in any of the analyzed genetic model. We found the same negative association in stratified analyses by ethnicity, source of controls, and sample size. Our meta-analysis provides an estimate that the presence of cyclin D1 polymorphism may not confer susceptibility to breast cancer.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Ormandy CJ et al. Cyclin D1, EMS1 and 11q13 amplification in breast cancer. Breast Cancer Res Treat. 2003;78(3):323–35.

    Article  CAS  PubMed  Google Scholar 

  2. Motokura T et al. A novel cyclin encoded by a bcl1-linked candidate oncogene. Nature. 1991;350(6318):512–5.

    Article  CAS  PubMed  Google Scholar 

  3. Knudsen KE et al. Cyclin D1: polymorphism, aberrant splicing and cancer risk. Oncogene. 2006;25(11):1620–8.

    Article  CAS  PubMed  Google Scholar 

  4. Reed SI. The role of p34 kinases in the G1 to S-phase transition. Annu Rev Cell Biol. 1992;8:529–61.

    Article  CAS  PubMed  Google Scholar 

  5. Diehl JA. Cycling to cancer with cyclin D1. Cancer Biol Ther. 2002;1(3):226–31.

    Article  CAS  PubMed  Google Scholar 

  6. Sherr CJ. Cancer cell cycles. Science. 1996;274(5293):1672–7.

    Article  CAS  PubMed  Google Scholar 

  7. Sutherland RL, Musgrove EA. Cyclin D1 and mammary carcinoma: new insights from transgenic mouse models. Breast Cancer Res. 2002;4(1):14–7.

    Article  CAS  PubMed  Google Scholar 

  8. Ewen ME et al. Functional interactions of the retinoblastoma protein with mammalian D-type cyclins. Cell. 1993;73(3):487–97.

    Article  CAS  PubMed  Google Scholar 

  9. Bala S, Peltomaki P. Cyclin D1 as a genetic modifier in hereditary nonpolyposis colorectal cancer. Cancer Res. 2001;61(16):6042–5.

    CAS  PubMed  Google Scholar 

  10. Casson AG et al. Cyclin D1 polymorphism (G870A) and risk for esophageal adenocarcinoma. Cancer. 2005;104(4):730–9.

    Article  CAS  PubMed  Google Scholar 

  11. Hou X et al. Cyclin D1 gene polymorphism and susceptibility to childhood acute lymphoblastic leukemia in a Chinese population. Int J Hematol. 2005;82(3):206–9.

    Article  CAS  PubMed  Google Scholar 

  12. Hung RJ et al. Sequence variants in cell cycle control pathway, X-ray exposure, and lung cancer risk: a multicenter case-control study in Central Europe. Cancer Res. 2006;66(16):8280–6.

    Article  CAS  PubMed  Google Scholar 

  13. Zheng Y et al. Cyclin D1 polymorphism and risk for squamous cell carcinoma of the head and neck: a case-control study. Carcinogenesis. 2001;22(8):1195–9.

    Article  CAS  PubMed  Google Scholar 

  14. Grieu F et al. Lack of association between CCND1 G870A polymorphism and the risk of breast and colorectal cancers. Anticancer Res. 2003;23(5b):4257–9.

    CAS  PubMed  Google Scholar 

  15. Ceschi M et al. The effect of cyclin D1 (CCND1) G870A-polymorphism on breast cancer risk is modified by oxidative stress among Chinese women in Singapore. Carcinogenesis. 2005;26(8):1457–64.

    Article  CAS  PubMed  Google Scholar 

  16. Shu XO et al. Association of cyclin D1 genotype with breast cancer risk and survival. Cancer Epidemiol Biomarkers Prev. 2005;14(1):91–7.

    CAS  PubMed  Google Scholar 

  17. Onay UV et al. Combined effect of CCND1 and COMT polymorphisms and increased breast cancer risk. BMC Cancer. 2008;8:6.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  18. Mantel N, Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst. 1959;22(4):719–48.

    CAS  PubMed  Google Scholar 

  19. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7(3):177–88.

    Article  CAS  PubMed  Google Scholar 

  20. Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med. 2002;21(11):1539–58.

    Article  PubMed  Google Scholar 

  21. Egger M et al. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315(7109):629–34.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  22. Abramson VG et al. Cyclin D1b in human breast carcinoma and coexpression with cyclin D1a is associated with poor outcome. Anticancer Res. 2010;30(4):1279–85.

    CAS  PubMed  PubMed Central  Google Scholar 

  23. Labonte MJ et al. The Cyclin D1 (CCND1) A870G polymorphism predicts clinical outcome to lapatinib and capecitabine in HER2-positive metastatic breast cancer. Ann Oncol. 2012;23(6):1455–64.

    Article  CAS  PubMed  Google Scholar 

  24. Onay VU et al. SNP-SNP interactions in breast cancer susceptibility. BMC Cancer. 2006;6:114.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  25. Al DA, Qureshi S, Al Saleh KA, Al Qahtani FH, Aleem A, AlSaif A, et al. Studies on the methods of diagnosis and biomarkersused in early detection of breast cancer in the Kingdom of Saudi Arabia: an overview. World J Med Sci. 2013;8(1):36–47.

    Google Scholar 

  26. Krippl P et al. The 870G > A polymorphism of the cyclin D1 gene is not associated with breast cancer. Breast Cancer Res Treat. 2003;82(3):165–8.

    Article  CAS  PubMed  Google Scholar 

  27. Forsti A et al. Single nucleotide polymorphisms in breast cancer. Oncol Rep. 2004;11(4):917–22.

    PubMed  Google Scholar 

  28. Yu CP et al. Tumor susceptibility and prognosis of breast cancer associated with the G870A polymorphism of CCND1. Breast Cancer Res Treat. 2008;107(1):95–102.

    Article  CAS  PubMed  Google Scholar 

  29. Naidu R, Yip CH, Taib NA. Polymorphisms of HER2 Ile655Val and cyclin D1 (CCND1) G870A are not associated with breast cancer risk but polymorphic allele of HER2 is associated with nodal metastases. Neoplasma. 2008;55(2):87–95.

    CAS  PubMed  Google Scholar 

  30. Driver KE et al. Association of single-nucleotide polymorphisms in the cell cycle genes with breast cancer in the British population. Carcinogenesis. 2008;29(2):333–41.

    Article  CAS  PubMed  Google Scholar 

  31. Millar EK et al. Cyclin D1b protein expression in breast cancer is independent of cyclin D1a and associated with poor disease outcome. Oncogene. 2009;28(15):1812–20.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  32. Yaylim-Eraltan I et al. Breast cancer and cyclin D1 gene polymorphism in Turkish women. In Vivo. 2009;23(5):767–72.

    CAS  PubMed  Google Scholar 

  33. Justenhoven C et al. Polymorphic loci of E2F2, CCND1 and CCND3 are associated with HER2 status of breast tumors. Int J Cancer. 2009;124(9):2077–81.

    Article  CAS  PubMed  Google Scholar 

  34. Haiman CA et al. Screening and association testing of common coding variation in steroid hormone receptor co-activator and co-repressor genes in relation to breast cancer risk: the multiethnic cohort. BMC Cancer. 2009;9:43.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  35. Canbay E et al. CCND1 and CDKN1B polymorphisms and risk of breast cancer. Anticancer Res. 2010;30(7):3093–8.

    CAS  PubMed  Google Scholar 

  36. Jelonek K et al. Association between single-nucleotide polymorphisms of selected genes involved in the response to DNA damage and risk of colon, head and neck, and breast cancers in a Polish population. J Appl Genet. 2010;51(3):343–52.

    Article  CAS  PubMed  Google Scholar 

  37. Jeon S et al. Combined genetic effect of CDK7 and ESR1 polymorphisms on breast cancer. Breast Cancer Res Treat. 2010;121(3):737–42.

    Article  CAS  PubMed  Google Scholar 

  38. Absenger, G., et al. (2013). A common and functional gene variant in the vascular endothelial growth factor a predicts clinical outcome in early-stage breast cancer. Mol Carcinog.

  39. Bedewy AM et al. Association of cyclin D1 A870G polymorphism with two malignancies: acute lymphoblastic leukemia and breast cancer. J BUON. 2013;18(1):227–38.

    CAS  PubMed  Google Scholar 

  40. Roy PG, Thompson AM. Cyclin D1 and breast cancer. Breast. 2006;15(6):718–27.

    Article  PubMed  Google Scholar 

  41. Simpson JF et al. Amplification of CCND1 and expression of its protein product, cyclin D1, in ductal carcinoma in situ of the breast. Am J Pathol. 1997;151(1):161–8.

    CAS  PubMed  PubMed Central  Google Scholar 

  42. Gillett CE et al. Cyclin D1 and associated proteins in mammary ductal carcinoma in situ and atypical ductal hyperplasia. J Pathol. 1998;184(4):396–400.

    Article  CAS  PubMed  Google Scholar 

  43. Betticher DC et al. Alternate splicing produces a novel cyclin D1 transcript. Oncogene. 1995;11(5):1005–11.

    CAS  PubMed  Google Scholar 

  44. Wu J et al. Identification of the cyclin D1b mRNA variant in mouse. Mol Biol Rep. 2009;36(5):953–7.

    Article  CAS  PubMed  Google Scholar 

  45. Lu F, Gladden AB, Diehl JA. An alternatively spliced cyclin D1 isoform, cyclin D1b, is a nuclear oncogene. Cancer Res. 2003;63(21):7056–61.

    CAS  PubMed  Google Scholar 

  46. Pabalan N et al. Cyclin D1 Pro241Pro (CCND1-G870A) polymorphism is associated with increased cancer risk in human populations: a meta-analysis. Cancer Epidemiol Biomarkers Prev. 2008;17(10):2773–81.

    Article  CAS  PubMed  Google Scholar 

  47. Lu C et al. CCND1 G870A polymorphism contributes to breast cancer susceptibility: a meta-analysis. Breast Cancer Res Treat. 2009;116(3):571–5.

    Article  CAS  PubMed  Google Scholar 

  48. Sergentanis TN, Economopoulos KP. Cyclin D1 G870A polymorphism and breast cancer risk: a meta-analysis comprising 9,911 cases and 11,171 controls. Mol Biol Rep. 2011;38(8):4955–63.

    Article  CAS  PubMed  Google Scholar 

  49. Cui J, Shen L, Wang Y. Specific CCND1 G870A alleles associated with breast cancer susceptibility: a meta-analysis of 5,528 cases and 5,353 controls. Asian Pac J Cancer Prev. 2012;13(10):5023–5.

    Article  PubMed  Google Scholar 

  50. Yang J et al. Cyclin D1 G870A polymorphism and breast cancer risk: a meta-analysis involving 23,998 subjects. Oncol Res. 2011;19(12):519–25.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Oncology, The First Affiliated Hospital of Xinxiang Medical University, Xinxiang, China

    XiaoRui Li, XiaoQing Huo, WeiWei Li, QingHui Yang, Ying Wang & XiaoChun Kang

Authors
  1. XiaoRui Li
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. XiaoQing Huo
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. WeiWei Li
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. QingHui Yang
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Ying Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. XiaoChun Kang
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to XiaoRui Li.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Li, X., Huo, X., Li, W. et al. Genetic association between cyclin D1 polymorphism and breast cancer susceptibility. Tumor Biol. 35, 11959–11965 (2014). https://doi.org/10.1007/s13277-014-2489-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13277-014-2489-5

Keywords

Search

Navigation